3,4-methylenedioxyamphetamine has been researched along with Mitochondrial Diseases in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sutton, MB | 1 |
| Windischbauer, S | 1 |
| Sutton, EM | 1 |
| Weixler, D | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Mitochondrial Diseases
| Article | Year |
|---|---|
Resilience, childhood disability and the Internet--case report.
Topics: Adolescent; Community Participation; Diet, Ketogenic; Disabled Children; Epilepsies, Myoclonic; Foll | 2010 |